Arylestarase and oxidative stress in operating room personnel.

BACKGROUND Long-term occupational exposure to trace concentrations of volatile anesthetics is known to have adverse effects on the health of exposed personnel. OBJECTIVES We investigated paraoxonase-1 (PON1) and arylesterase (ARE), as well as antioxidant status (TAS) and total oxidant status (TOS) levels in anesthesia personnel (AP) who were chronically exposed to inhalation anesthetics, and compared them with levels in a control group. MATERIAL AND METHODS We designed a comparative prospective study with 50 female subjects. The first cohort included 25 full-time female workers in operating rooms in two locations in the Antalya Education and Research Hospital in Antalya, Turkey. The control group was comprised of 25 female individuals working in the same hospitals without any work-related exposure to hazardous agents. RESULTS Serum ARE activity and TAS levels were significantly reduced (p = 0.04 and p < 0.0001, respectively), whereas TOS and OSI levels were found to be significantly higher (p = 0.01 and p < 0.0001, respectively) in AP. However, there were no significant differences in PON1 activity, PON1/HDL-C, ARE/HDL-C, and PON1/ARE (p = 0.30, p = 0.5, p = 0.1 and p = 0.7, respectively) when the two groups were contrasted. CONCLUSIONS According to the results of this study, depending on the putative role of PON/ARE in oxidant stress-related diseases, particularly atherosclerosis and cancer, AP might be considered a risk group for the development of atherosclerosis and many other diseases.

[1]  M. Marusic,et al.  Immunological disturbances in anaesthetic personnel chronically exposed to high occupational concentrations of nitrous oxide and halothane , 1991, Anaesthesia.

[2]  Dan S. Tawfik,et al.  The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux* , 2006, Journal of Biological Chemistry.

[3]  O. Erel,et al.  Increased oxidative stress in patients with hydatidiform mole. , 2003, Swiss medical weekly.

[4]  A. Otocka-Kmiecik,et al.  The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase. , 2009, Postepy higieny i medycyny doswiadczalnej.

[5]  Z. Baysal,et al.  Oxidative status and DNA damage in operating room personnel. , 2009, Clinical biochemistry.

[6]  A. Emili,et al.  Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor* , 2001, The Journal of Biological Chemistry.

[7]  P. Durrington,et al.  How high-density lipoprotein protects against the effects of lipid peroxidation , 2000, Current opinion in lipidology.

[8]  J. Erdmann,et al.  Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Aydın,et al.  Effect of Volatile Anesthetics on Oxidative Stress Due to Occupational Exposure , 2005, World Journal of Surgery.

[10]  A. Sinclair,et al.  Free radicals and antioxidant systems in health and disease. , 1990, British journal of hospital medicine.

[11]  M. Valko,et al.  Free radicals, metals and antioxidants in oxidative stress-induced cancer. , 2006, Chemico-biological interactions.

[12]  De-Pei Liu,et al.  Paraoxonase gene polymorphisms, oxidative stress, and diseases , 2003, Journal of Molecular Medicine.

[13]  H. K. Wilson,et al.  Effects of trace levels of nitrous oxide on psychomotor performance. , 1983, Scandinavian journal of work, environment & health.

[14]  T. Andreoli Free radicals and oxidative stress. , 2000, The American journal of medicine.

[15]  P. Durrington,et al.  Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein , 1991, FEBS letters.

[16]  O. Erel A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. , 2003, Clinical biochemistry.

[17]  J. Jackson,et al.  Oxidant-induced DNA damage of target cells. , 1988, The Journal of clinical investigation.

[18]  W. Wąsowicz,et al.  Oxidative DNA damage and oxidative stress in subjects occupationally exposed to nitrous oxide (N(2)O). , 2012, Mutation research.

[19]  J. Coombes,et al.  Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. , 2012, Gene.

[20]  J. Plummer,et al.  Free Radical Formation In Vivo and Hepatotoxicity due to Anesthesia with Halothane , 1982, Anesthesiology.

[21]  M. Abdollahi,et al.  Oxidative stress in operating room personnel: occupational exposure to anesthetic gases , 2005, Human & experimental toxicology.

[22]  H. Kruth Lipoprotein cholesterol and atherosclerosis. , 2001, Current molecular medicine.

[23]  Z. Ďuračková Some current insights into oxidative stress. , 2010, Physiological research.

[24]  B. La Du,et al.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. , 1998, The Journal of clinical investigation.

[25]  M. Chandrasekhar,et al.  Evaluation of genetic damage in operating room personnel exposed to anaesthetic gases. , 2006, Mutagenesis.

[26]  A. Smolen,et al.  Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[27]  M. Vessey Epidemiological studies of the occupational hazards of anaesthesia‐a review * , 1978, Anaesthesia.

[28]  Edward J. Driscoll,et al.  Occupational Disease in Dentistry and Chronic Exposure to Trace Anesthetic Gases , 1980 .

[29]  B. La Du,et al.  The human serum paraoxonase/arylesterase polymorphism. , 1983, American journal of human genetics.

[30]  O. Erel,et al.  A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.